https://www.selleckchem.com/pr....oducts/solcitinib.ht
6 ± 6.6 days, respectively; p less then 0.001) and lower hospital charges ($54,899.25 vs $75,246.00, p less then 0.001) but no significant difference in hospitalization or 30-day readmissions. Conclusions ERCP is associated with reduced mortality compared with PTBD in pancreatic cancer patients, highlighting the critical role of ERCP in the management of biliary obstruction from pancreatic cancer.Infertility affects about 8 to 12% of couples of childbearing age around the world, and is recognized as a global public health issue by th
Like
Comment
Share
